Postmortem observation of collagenous lead tip region fibrosis as a rare complication of DBS

Movement Disorders

Volumn 27, Issue 4, 2012, Pages 565-569

  Vedam Mai, Vinata ^a   Yachnis, Anthony ^a   Ullman, Michael ^a   Javedan, Saman P ^b   Okun, Michael S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Lee Memorial Hospital   (United States)

Author keywords

Adverse events; DBS complications; Fracture; Parkinson's

Indexed keywords

HEMOSIDERIN; LEAD;

AGED; ARTICLE; AUTOPSY; BRAIN DEPTH STIMULATION; CASE REPORT; CHRONIC INFLAMMATION; ELECTRODE; FIBROSIS; GLIOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; SAFETY;

AGED; AUTOPSY; DEEP BRAIN STIMULATION; FIBRILLAR COLLAGENS; FIBROSIS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; PARKINSON DISEASE;

EID: 84859425727     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24916     Document Type: Article

References (16)

1. Haberler C, Alesch F, Mazal PR, et al. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Ann Neurol 2000; 48: 372-376.
2. Sun DA, Yu H, Spooner J, et al. Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg 2008; 109: 325-329.
3. Burbaud P, Vital A, Rougier A, et al. Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis. Neurology 2002; 59: 1982-1984.
4. Vedam-Mai V, Krock N, Ullman M, et al. The national DBS brain tissue network pilot study: need for more tissue and more standardization. Cell Tissue Bank 2011; 12: 219-231.
5. Volkmann J. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol 2004; 21: 6-17.
6. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: postoperative issues. Mov Disord 2006; 21( Suppl 14): S219-S237.
7. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov Disord 2010; 25: 232-238.
8. Mann JM, Foote KD, Garvan CW, et al. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry 2009; 80: 794-797.
9. Morishita T, Foote KD, Burdick AP, et al. Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies. Parkinsonism Relat Disord 2010; 16: 153-162.
10. Polikov VS, Tresco PA, Reichert WM. Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods 2005; 148: 1-18.
11. Giordana MT, Attanasio A, Cavalla P, Migheli A, Vigliani MC, Schiffer D. Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol Appl Neurobiol 1994; 20: 163-174.
12. Edell DJ, Toi VV, McNeil VM, Clark LD. Factors influencing the biocompatibility of insertable silicon microshafts in cerebral cortex. IEEE Trans Biomed Eng 1992; 39: 635-643.
13. Shain W, Spataro L, Dilgen J, et al. Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies. IEEE Trans Neural Syst Rehabil Eng 2003; 11: 186-188.
14. Liu X, McCreery DB, Carter RR, Bullara LA, Yuen TG, Agnew WF. Stability of the interface between neural tissue and chronically implanted intracortical microelectrodes. IEEE Trans Rehabil Eng 1999; 7: 315-326.
15. Hughes PS, Krcek JP, Hobson DE, Del Bigio MR. An unusual inflammatory response to implanted deep brain electrodes. Can J Neurol Sci 2011; 38: 168-170.
16. McConnell GC, Rees HD, Levey AI, Gutekunst CA, Gross RE, Bellamkonda RV. Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration. J Neural Eng 2009; 6: 056003.